Executive Vice President – Head of Oncology
Evotec
Executive Vice President – Head of Oncology
Evotec
Global drug-discovery services via partnerships
The Head of Oncology is a senior scientific and strategic leadership role responsible for shaping and executing the R&D strategy within the oncology therapeutic area as well as leading strategic partnerships in the field. Reporting to the Head of Therapeutic Areas, this role drives innovation, identifies high-impact opportunities, and steers cross-functional efforts to build a competitive and differentiated pipeline. The role operates in a matrix environment, influencing internal and external stakeholders to position Evotec as a leader in the field.
Responsibilities
Required Qualification
For Italy: In compliance with fundamental ethical and professional principles and with Legislative Decree 198/2006, Evotec is an Equal Opportunity Employer committed to fostering a safe, diverse, and inclusive workplace built on mutual respect. We provide equal employment opportunities to all qualified candidates and employees based on their skills, experience, and professional qualifications. In line with our ethical and professional principles, all employment-related decisions, including recruitment and selection processes, are made fairly and without any form of discrimination. All qualified candidates will be considered for employment regardless of race, color, sex, age, disability, genetic information, gender expression, gender identity, nationality, religion, sexual orientation, or any other characteristic protected under applicable law.
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec provides research and development services for drug discovery and development through strategic partnerships with pharma, biotech, and academic groups. Its work relies on proprietary platforms such as iPSC-derived cellular models and machine learning to run experiments and analyze data from early discovery through clinical development, often using patient-derived materials to support precision medicine. Unlike many competitors, Evotec offers an integrated, end-to-end R&D platform within collaborations, combining data-driven biology with cell- and gene-therapy capabilities rather than selling standalone tools. Its goal is to bring new and better medicines to patients faster and at lower cost by making the drug development process more efficient through partnerships.
Explore more opportunities at Evotec